Eli Lilly and Company (LLY)
Debt-to-assets ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 28,527,100 | 29,045,400 | 23,730,400 | 24,559,900 | 18,320,800 | 17,923,600 | 18,158,400 | 18,880,500 | 14,737,500 | 14,143,800 | 14,692,000 | 15,152,900 | 15,346,400 | 15,522,400 | 14,736,600 | 16,199,600 | 16,586,600 | 16,334,600 | 15,064,400 | 13,982,300 |
Total assets | US$ in thousands | 78,714,900 | 75,606,900 | 71,874,800 | 63,943,500 | 64,006,300 | 57,915,500 | 54,814,000 | 53,163,000 | 49,489,800 | 47,461,500 | 47,063,600 | 46,919,300 | 48,806,000 | 48,187,000 | 47,809,000 | 46,838,300 | 46,633,100 | 43,946,000 | 41,967,000 | 41,102,800 |
Debt-to-assets ratio | 0.36 | 0.38 | 0.33 | 0.38 | 0.29 | 0.31 | 0.33 | 0.36 | 0.30 | 0.30 | 0.31 | 0.32 | 0.31 | 0.32 | 0.31 | 0.35 | 0.36 | 0.37 | 0.36 | 0.34 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $28,527,100K ÷ $78,714,900K
= 0.36
The debt-to-assets ratio for Eli Lilly and Company has fluctuated over the past few years, ranging from a low of 0.29 to a high of 0.38. This ratio indicates the proportion of the company's assets financed with debt, with higher ratios suggesting a greater reliance on debt financing.
From March 31, 2020, to December 31, 2021, the debt-to-assets ratio remained relatively stable, hovering around the 0.35 mark. However, there was a slight decrease observed in the ratio from June 30, 2021, to June 30, 2022, where it dropped from 0.31 to 0.30.
The ratio increased notably in the following quarters, with spikes observed on March 31, 2023, and September 30, 2024, when it reached 0.38. However, there were also periods of decline seen, such as the decrease from June 30, 2022, to September 30, 2022, where the ratio decreased from 0.31 to 0.30.
Overall, the debt-to-assets ratio for Eli Lilly and Company has shown some fluctuations but has generally remained within a moderate range, indicating a balanced mix of debt and assets in the company's capital structure.
Peer comparison
Dec 31, 2024